Michiel Strijbos, MD, GasthuisZusters Antwerpen, Antwerp, Belgium, discusses the increased focus on de-escalation strategies in recent years, which he partly attributes to better communication between physicians and patient advocacy. Physicians tend to see patients in clinics and on wards and are often focused on acute toxicity over long-term toxicity. However, recent investigations into de-escalation strategies have been aiming to decrease the burden of long-term toxicities for patients while not adversely impacting clinical outcomes. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
